PRFXNasdaqPharmaceutical PreparationsFiscal year ends December 31
PRF Technologies Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$0.71−0.07 (-8.88%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Margins need revenue and profit figures
This company does not report the lines needed to calculate margins.
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|
Returns and balance sheet
9 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | -185.2% | -96.9% | |
| Return on assets | – | -42.7% | -60.8% | |
| Current ratio | – | 18.51 | 1.78 | |
| Interest coverage | – | -6.2× | – | |
| Diluted shares | – | 0M | 1M |
Where the cash went
Fiscal 2021 to 2025, five years combined
PRF Technologies generated $36.27M from operations and spent $80.00K on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$36.27M
Used
$80.00K
Capital expenditure$80.00K100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-29541.2%
×Asset turnover0.00×
×Equity multiplier1.59×
=Return on equity, FY2025-96.9%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -29541.2% | 0.00× | 1.59× | -96.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$5.02M
- Cash generatingOperating cash flow above zero-$3.96M
- Return on assets improvedROA up on the prior year-146.9% → -111.0%
- Earnings backed by cashOperating cash flow above net income-$3.96M vs -$5.02M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.81 → 1.78
- No dilutionShare count did not rise0M → 1M
- Gross margin improvedGross margin up on the prior year– → -311.76%
- More efficientAsset turnover rose0.00 → 0.00